Inogen, Inc.
US ˙ NasdaqGS ˙ US45780L1044

SecurityINGN / Inogen, Inc.
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership242,157 shares
Latest Disclosed Value $ 1,496,530
Qube Research & Technologies Ltd reports 7.90% decrease in ownership of INGN / Inogen, Inc.

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 242,157 shares of Inogen, Inc. (US:INGN) valued at $1,496,530 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 262,930 shares of Inogen, Inc.. This represents a change in shares of -7.90% during the quarter. The current value of the position is $1,552,226 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INOGEN COM 45780L104 242,157 -20,773 -7.90 1,497 -15.29 0.0017
2026-02-17 2025-12-31 13F INOGEN COM 45780L104 262,930 84,646 47.48 1,767 21.29 0.0018
2025-11-14 2025-09-30 13F INOGEN COM 45780L104 178,284 89,071 99.84 1,457 132.22 0.0015
2025-08-14 2025-06-30 13F INOGEN COM 45780L104 89,213 24,628 38.13 627 36.30 0.0006
2025-05-15 2025-03-31 13F INOGEN COM 45780L104 64,585 -76,605 -54.26 460 -64.45 0.0005
2025-02-14 2024-12-31 13F INOGEN COM 45780L104 141,190 88,459 167.76 1,295 153.23 0.0017
2024-11-14 2024-09-30 13F INOGEN COM 45780L104 52,731 52,731 511 0.0008
2024-02-13 2023-12-31 13F INOGEN COM 45780L104 0 -8,292 -100.00 0 -100.00
2023-11-13 2023-09-30 13F INOGEN COM 45780L104 8,292 -140,761 -94.44 43 -97.50 0.0001
2023-08-14 2023-06-30 13F INOGEN COM 45780L104 149,053 127,810 601.66 1,722 549.43 0.0063
2023-05-15 2023-03-31 13F INOGEN COM 45780L104 21,243 21,243 265 0.0011
2022-05-09 2022-03-31 13F INOGEN COM 45780L104 0 -11,919 -100.00 0 -100.00
2022-02-10 2021-12-31 13F/A-1 INOGEN COM 45780L104 11,919 11,919 405 0.0031
2022-02-01 2021-12-31 13F INOGEN COM 45780L104 11,919 11,919 405 0.0031
2021-11-12 2021-09-30 13F INOGEN COM 45780L104 0 -8,975 -100.00 0 -100.00
2021-08-13 2021-06-30 13F INOGEN COM 45780L104 8,975 8,975 585 0.0067
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.